lucentis 10 mg/ml soluţie injectabilă
novartis pharma ag - ranibizumabum - soluţie injectabilă - 10 mg/ml
diclofenac chirmis 10 mg/g
tis farmaceutic sa - romania - diclofenacum - gel - 10mg/g - medicamente topice pentru dureri articulare si musculare antiinflamatoare nesteroidiene de uz topic
proclorperazina sintofarm 25 mg (vezi n05ab04)
sintofarm sa - romania - prochlorperazinum - supoz. - 25mg - antipsihotice fenotiazine cu structura piperazinica
technescan sestamibi 1 mg
mallinckrodt medical b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
vigamox 5 mg/ml
novartis farmaceutica, s.a. - spania - moxifloxacinum - pic. oft., sol. - 5mg/ml - antiinfectioase antiinfectioase
technescan sestamibi 1 mg
curium netherlands b.v. - olanda - radiofarmaceutice - trusa (kit) pt. preparate radiofarmaceutice - 1mg - aparat cardiovascular compusi cu technetium (99mtc)
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, clorhidrat de metformină - diabetul zaharat, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - virusul gripei de suprafață (hemaglutinină și neuraminidază) de tulpina a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - imunizarea activă împotriva subtipului h5n1 al virusului gripal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
troxerutin chirmis 20 mg/g
tis farmaceutic sa - romania - troxerutinum - gel - 20 mg/g - medicatia capilarelor (capilarotonice) bioflavonoide
ciclosporina sandoz 10 mg
novartis pharma gmbh - germania - ciclosporinum - caps. moi - 10mg - imunosupresoare inhibitori de calcineurina